Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1125 of 3173 entries
View as:

A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)

Phase: N/A Priority: Normal
NCT ID: NCT00457470 Org: User:
Start: 06/30/07 End: - Due: -

Patterns of Real-World Isavuconazole Use - a Study of Patients With Mucormycosis or Invasive Aspergillosis

Phase: N/A Priority: Normal
NCT ID: NCT04550936 Org: User:
Start: 03/10/21 End: 12/23/23 Due: 12/23/24

Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00706706 Org: User:
Start: 07/31/08 End: 08/31/11 Due: 08/31/12

RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study

Phase: N/A Priority: Normal
NCT ID: NCT06790420 Org: User:
Start: 01/31/25 End: 03/14/25 Due: 03/14/26

Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years

Phase: N/A Priority: Normal
NCT ID: NCT00161954 Org: User:
Start: 03/31/04 End: 05/31/04 Due: 05/31/05

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT04458259 Org: User:
Start: 09/24/20 End: 11/15/24 Due: 11/15/25

The Study is to Evaluate the Effect of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03126721 Org: User:
Start: 04/18/17 End: 07/11/17 Due: 07/11/18

SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00083889 Org: User:
Start: 08/31/04 End: 09/30/08 Due: 09/30/09

Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections

Phase: N/A Priority: Normal
NCT ID: NCT05639647 Org: User:
Start: 04/18/23 End: 06/24/26 Due: 06/24/27

Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.

Phase: N/A Priority: Normal
NCT ID: NCT06479954 Org: User:
Start: 07/30/24 End: 02/25/27 Due: 02/25/28

A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Centers for Blood Related Diseases

Phase: N/A Priority: Normal
NCT ID: NCT05742217 Org: User:
Start: 05/26/23 End: 05/31/26 Due: 05/31/27

Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031

Phase: N/A Priority: Normal
NCT ID: NCT03573882 Org: User:
Start: 06/06/18 End: 11/12/24 Due: 11/12/25

A Study to Learn How the Study Medicine Called [14C]PF-07054894 is Processed by the Body

Phase: N/A Priority: Normal
NCT ID: NCT07009353 Org: User:
Start: 06/19/25 End: 09/05/25 Due: 09/05/26

A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01066481 Org: User:
Start: 04/30/10 End: 04/30/12 Due: 04/30/13

A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection

Phase: N/A Priority: Normal
NCT ID: NCT00720434 Org: User:
Start: 08/31/08 End: 03/31/10 Due: 03/31/11

Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT00460408 Org: User:
Start: 08/31/06 End: 02/29/12 Due: 02/28/13

PF-06741086 Long-term Treatment in Severe Hemophilia

Phase: N/A Priority: Normal
NCT ID: NCT03363321 Org: User:
Start: 05/30/18 End: 08/05/20 Due: 08/05/21

A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With Epoetin

Phase: N/A Priority: Normal
NCT ID: NCT01628120 Org: User:
Start: 05/31/12 End: 02/13/15 Due: 02/13/16

Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01430585 Org: User:
Start: 03/31/12 End: 12/31/12 Due: 12/31/13

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene

Phase: N/A Priority: Normal
NCT ID: NCT00444795 Org: User:
Start: 05/31/07 End: 03/31/15 Due: 03/31/16

Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00393939 Org: User:
Start: 02/28/07 End: 07/31/11 Due: 07/31/12

A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01469065 Org: User:
Start: 12/31/11 End: 05/31/12 Due: 05/31/13

To Evaluate Safety, Tolerability, Plasma Drug Levels And Other Biological Effects In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01045863 Org: User:
Start: 02/28/10 End: 06/30/10 Due: 06/30/11

Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers

Phase: N/A Priority: Normal
NCT ID: NCT00483353 Org: User:
Start: 07/31/07 End: - Due: -

Analgesic Efficacy Of Valdecoxib In Patients Following Bunion Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00653354 Org: User:
Start: 12/31/02 End: 03/31/03 Due: 03/31/04